Compile Data Set for Download or QSAR
Report error Found 554 of affinity data for UniProtKB/TrEMBL: P37840
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481157(US10906900, Reference 25a)
Affinity DataKd:  0.490nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481157(US10906900, Reference 25a)
Affinity DataKd:  0.490nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481149(US10906900, Reference 22a)
Affinity DataKd:  0.530nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481149(US10906900, Reference 22a)
Affinity DataKd:  0.530nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481158(US10906900, Reference 25b)
Affinity DataKd:  0.730nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481153(US10906900, Reference 22f)
Affinity DataKd:  0.790nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481156(US10906900, Reference 22d)
Affinity DataKd:  1nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50545096(CHEMBL4637732)
Affinity DataKd:  1nMAssay Description:Binding affinity to human wlid-type alpha-synuclein by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481156(US10906900, Reference 22d)
Affinity DataKd:  1nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50614057(CHEMBL5286894)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Alpha-synuclein (unknown origin) fibrilsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481159(US10906900, Reference 25c)
Affinity DataKd:  1.27nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481150(US10906900, Reference 22b)
Affinity DataKd:  1.40nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481150(US10906900, Reference 22b)
Affinity DataKd:  1.40nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103964(CHEMBL3593932)
Affinity DataKi:  2.10nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50614056(CHEMBL5274551)
Affinity DataKi:  2.30nMAssay Description:Binding affinity to Alpha-synuclein (unknown origin) fibrils assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481160(US10906900, Reference 28)
Affinity DataKd:  2.40nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481160(US10906900, Reference 28)
Affinity DataKd:  2.40nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481151(US10906900, Reference 22c)
Affinity DataKd:  3.25nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481151(US10906900, Reference 22c)
Affinity DataKd:  3.25nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633984(CHEMBL5404722)
Affinity DataKi:  3.5nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103961(CHEMBL3593930)
Affinity DataKi:  3.5nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103936(CHEMBL3593928)
Affinity DataKi:  3.80nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50614060(CHEMBL5270314)
Affinity DataKd:  3.80nMAssay Description:Binding affinity to C-terminal His6-tagged human Alpha-synuclein fibrils (1 to 97 residues) expressed in Escherichia coli assessed as dissociation co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50104103(CHEMBL3593911)
Affinity DataKi:  4.20nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481149(US10906900, Reference 22a)
Affinity DataKi:  4.70nMAssay Description:Table 5: Fresh solutions of the test compounds (2.5 mM in DMSO) are diluted in PBS pH7.4, at concentrations between 0.5 nM and 5 μM in the prese...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM207889(US9266832, Cpd046)
Affinity DataEC50:  7nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50545088(CHEMBL4633757)
Affinity DataKd:  8.20nMAssay Description:Binding affinity to human wlid-type alpha-synuclein by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633992(CHEMBL5413730)
Affinity DataKi:  8.5nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103964(CHEMBL3593932)
Affinity DataKd:  8.90nMAssay Description:Binding affinity to recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1 hr by scintillation countingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633986(CHEMBL5436166)
Affinity DataKi:  9.20nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633998(CHEMBL5435534)
Affinity DataKi:  9.40nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50582842(CHEMBL5087695)
Affinity DataKd:  10nMAssay Description:Binding affinity to recombinant human alpha-syn aggregates assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680874(US12012394, Compound TZ64-105)
Affinity DataKi:  10nMAssay Description:α-Synuclein recombinant protein was produced in E. coli. BL21(DE3)RIL E. coli were transformed with a pRK172 bacterial expression plasmid contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2024
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680875(US12012394, Compound TZ64-19)
Affinity DataKi:  10.4nMAssay Description:α-Synuclein recombinant protein was produced in E. coli. BL21(DE3)RIL E. coli were transformed with a pRK172 bacterial expression plasmid contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2024
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680876(US12012394, Compound TZ66-16)
Affinity DataKi:  11nMAssay Description:α-Synuclein recombinant protein was produced in E. coli. BL21(DE3)RIL E. coli were transformed with a pRK172 bacterial expression plasmid contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2024
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50545097(CHEMBL4634055)
Affinity DataKd:  11nMAssay Description:Binding affinity to human wlid-type alpha-synuclein by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103979(CHEMBL3593904)
Affinity DataKi:  12nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680873(US12012394, Compound TZ64-102)
Affinity DataKi:  12nMAssay Description:α-Synuclein recombinant protein was produced in E. coli. BL21(DE3)RIL E. coli were transformed with a pRK172 bacterial expression plasmid contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2024
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50103934(CHEMBL3593926)
Affinity DataKi:  13nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM207891(US9266832, Cpd084 | US9266832, Cpd048)
Affinity DataEC50:  13nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM207875(US9266832, Cpd032)
Affinity DataEC50:  14nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM481153(US10906900, Reference 22f)
Affinity DataKi:  14.8nMAssay Description:Table 5: Fresh solutions of the test compounds (2.5 mM in DMSO) are diluted in PBS pH7.4, at concentrations between 0.5 nM and 5 μM in the prese...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680871(US12012394, Compound TZ64-55)
Affinity DataKi:  15nMAssay Description:α-Synuclein recombinant protein was produced in E. coli. BL21(DE3)RIL E. coli were transformed with a pRK172 bacterial expression plasmid contai...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/19/2024
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50104109(CHEMBL3593922)
Affinity DataKi:  15nMAssay Description:Displacement of Thio-T from recombinant alpha-synuclein (unknown origin) expressed in Escherichia coli after 1.5 hrs by fluorescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633991(CHEMBL5420714)
Affinity DataKi:  15nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM207874(US9266832, Cpd031)
Affinity DataEC50:  16nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50633993(CHEMBL5405459)
Affinity DataKi:  16nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50185987(2-(1-(6-((2-fluoroethyl)(methyl)amino)naphthalen-2...)
Affinity DataKd:  16.1nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50185987(2-(1-(6-((2-fluoroethyl)(methyl)amino)naphthalen-2...)
Affinity DataKd:  16.1nMAssay Description:Table 6 & 7: Fresh solutions of each test compound (2.5 mM in DMSO) are diluted in PBS pH=7.4 at concentrations between 0.5 nM and 5 μM in the p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2021
Entry Details
US Patent

TargetAlpha-synuclein(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50634000(CHEMBL5414142)
Affinity DataKi:  17nMAssay Description:Competitive binding affinity to recombinant alpha-synuclein (unknown origin) assessed as inhibition constant incubated for 0.5 hrs by ThT-based fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
Displayed 1 to 50 (of 554 total ) | Next | Last >>
Jump to: